Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus

scientific article published on 11 January 2010

Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/0961203309356455
P8608Fatcat IDrelease_t7wtczczebd75hdoaoujaxr4lq
P698PubMed publication ID20064914

P50authorAnna Sysa-JedrzejowskaQ47087815
P2093author name stringD P McCauliffe
J Narbutt
A Lesiak
J Lukamowicz
A Wózniacka
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectsystemic lupus erythematosusQ1485
chloroquineQ422438
chloroquine phosphateQ27264629
P304page(s)683-688
P577publication date2010-01-11
P1433published inLupusQ6704846
P1476titleEffect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus
P478volume19

Reverse relations

cites work (P2860)
Q90594140Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes
Q52567976Analysis of predictive factors for treatment resistance and disease relapse in Takayasu's arteritis.
Q26996498Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus
Q92511809Association between Serum Matrix Metalloproteinase- (MMP-) 3 Levels and Systemic Lupus Erythematosus: A Meta-analysis
Q30513775Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy
Q39155625Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo
Q39044818Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function
Q38182192Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity?
Q53609113Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial.
Q38285841Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases
Q37827403Hydroxychloroquine: from malaria to autoimmunity
Q37991390Immunomodulatory effects of antimicrobial agents. Part II: antiparasitic and antifungal agents
Q28548561Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease
Q38557048Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
Q41911830Low concentration of chloroquine enhanced efficacy of cisplatin in the treatment of human ovarian cancer dependent on autophagy
Q34084599Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2
Q38026787New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.
Q36047368Stimulation of triple negative breast cancer cell migration and metastases formation is prevented by chloroquine in a pre-irradiated mouse model
Q38985926Strategies to limit immune-activation in HIV patients.
Q39432359Suppression of autophagy by chloroquine sensitizes 5-fluorouracil-mediated cell death in gallbladder carcinoma cells
Q38026775The beneficial role of vitamin D in systemic lupus erythematosus (SLE).
Q37947108The role of antimalarial agents in the treatment of SLE and lupus nephritis
Q39112090Treatment of preeclampsia with hydroxychloroquine: a review

Search more.